Delivery Order SPE2DB22D1202-SPE2DB25FVFY7
Award Date 7/30/25
Potential Completion Date 8/20/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,676.22 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product commonly used for therapeutic and cosmetic medical applications. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $12,851.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. The contract, awarded on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,823.64 for 50-unit vials of Xeomin, a botulinum toxin injection used for therapeutic and cosmetic applications. This firm fixed-price delivery order, awarded on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a non-competitive set-aside award issued under the company's larger indefinite delivery contract. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $26,819.52 delivery order to AmerisourceBergen Drug Corp for 200 unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. Issued on August 19, 2025, with an ultimate completion date of September 10, 2025, this firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,519.70 for 50-unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 5, 2025. The award was issued on August 14, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. This firm fixed-price delivery order, issued on August 14, 2025, with completion targeted for September 5, 2025, represents a non-competitive set-aside award drawn from a larger contract vehicle. The product will be performed and delivered from AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $10,941.84 for XEOMIN 50 unit vials, a botulinum toxin product used for therapeutic and cosmetic purposes. The contract, designated as firm fixed price with no set-aside, was awarded on September 18, 2025, with an ultimate completion date of October 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This firm fixed-price delivery order, valued at $8,381.10, is scheduled for completion by September 11, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's proven...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $33,524.40 for XEOMIN 100 unit vials under a firm fixed price contract with the Medical Supply Chain, a component of the Defense Logistics Agency. The award, issued on August 25, 2025, is scheduled for completion by September 16, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a competitive award with no set-aside designation and is issued as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitive award, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, carries firm fixed pricing and represents a non-set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...